Skip to content

Ayahuasca research published in 2024

Page 2 of 5: studies 21 to 40 of 95, newest first. Back to the ayahuasca overview

Studies

Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca: Erratum.

American Journal of Therapeutics November 1, 2024

The first sentence in the Limitations section of the abstract for “Psychedelic Therapy: A Primer for Primary Care Clinicians - N,N-Dimethyltryptamine and Ayahuasca” stated:“There has only been a single published double-blind randomized controlled trial on ayahuasca and 2 on DMT.” The end of this sentence is incorrect. There are no published, double-blind randomized controlled trials on DMT as...

Differentiation of Ayahuasca Samples According to Preparation Mode and Botanical Varieties Using Metabolomics.

Journal of Psychoactive Drugs October 29, 2024 Taynara Simão Matos, Flávia Da Silva Zandonadi, Alex Aparecido Rosini Silva et al.

Ayahuasca is a brew traditionally prepared with a mixture of Psychotria viridis leaves and Banisteriopsis caapi vine and has demonstrated therapeutic properties for depression. Knowledge of the brew composition is important to improve the therapeutic potential and decrease side effects if ayahuasca becomes an option for refractory depression treatment. Ultra-high performance liquid...

DOI: 10.1080/02791072.2024.2420059 (opens in new tab) Full text (opens in new tab) Banisteriopsis caapi Liquid chromatography Mass spectrometry Metabolomics +6

Ayahuasca drinking using a two-bottle choice procedure in male mice.

Scientific Reports October 23, 2024 Natali D. Kisaki, Yasmim A. Serra, Isa R S Rodrigues et al.

Ayahuasca has been proposed as a treatment for substance use disorders. However, because of its hallucinogenic properties, studies investigating its abuse potential are needed. The aim of the present study was to investigate voluntary ayahuasca drinking in male mice using a two-bottle choice procedure. Male mice were exposed to two bottles, one of water and one of ayahuasca (0.01, 0.03 or 0.1...

As mudanças psicológicas promovidas pela ayahuasca em participantes iniciantes: um estudo observacional longitudinal

Revista Neurociências October 16, 2024 Vitória Pereira de Menezes, Luis Felipe Batista, Vicente Meneguzzo et al.

Introdução. Os transtornos mentais apresentam alta incidência na população, mas as opções terapêuticas são limitadas por efeitos colaterais e baixa eficácia. Nesse cenário, a Ayahuasca, utilizada por povos indígenas há milênios, surge como alternativa para tratar condições como ansiedade e depressão. Objetivo. Avaliar as mudanças psicológicas em participantes iniciantes de cerimônias com...

Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency.

Journal of Psychoactive Drugs October 15, 2024 Jamie E Parnes, Mitch Earleywine

Despite increasing interest in psychedelics and their potential therapeutic effects, research on inhaled N,N-Dimethyltryptamine (DMT) remains limited. Inhaled DMT has a reputation for rapid, dramatic onset and a brief duration, but correlates of use frequency remain poorly understood. A sample recruited from relevant internet sites, including nearly 400 people who had inhaled DMT, reported...

Reassessing ayahuasca regulation in Brazil: strategic framing and cumulative gains

Drugs Education Prevention and Policy October 14, 2024 Felipe Krause 2 citations

Background In the early twentieth century, ayahuasca gained popularity in northern Brazil, causing political tension due to moral hostility. However, over the course of the century, despite the proscription of DMT and the intensification of the ‘War on Drugs’, three phases of cumulative political gains eventually led to the full regulation of ayahuasca, in 2010. How was this achieved?Methods...

Healing with Ayahuasca the Plant Teacher: Psychedelic Metaphoricity and Polyontologies.

Medical Anthropology October 2, 2024 Alex K. Gearin 1 citation

Shamans, neo-shamans, atheists, and others describe gaining special knowledge from drinking ayahuasca, supporting the cross-cultural idea of ayahuasca as a plant teacher. While secular enthusiasts interpret this metaphorically, animists and others take it literally. This article examines ontological collisions at a healing retreat in the Peruvian Amazon, considering Shipibo shamans and their...

A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers.

Journal of Psychopharmacology October 1, 2024 Jessica L Ables, Leah Israel, Olivia Wood et al. 17 citations

Harmine is a component of the hallucinogenic brew, Ayahuasca, which also contains the psychoactive compound, N, N-dimethyltryptamine. Whether pharmaceutical-grade harmine hydrochloride (HCl) has psychoactive effects, the doses at which these might occur, and the dose-response relationship to side effects and safety in humans are unknown. We conducted a Phase 1, open-label single ascending dose...

Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat

Journal of Psychopharmacology September 27, 2024 Daniel Meling, Klemens Egger, Jovin Mueller et al. 15 citations

Background: In recent years, both meditation and psychedelics have attracted rapidly increasing scientific interest. While the current state of evidence suggests the promising potential of psychedelics, such as psilocybin, to enhance meditative training, it remains equivocal whether these effects are specifically bound to psilocybin or if other classical psychedelics might show synergistic...

Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents

Neuroscience & Biobehavioral Reviews September 20, 2024 Isabel Werle, Leandro J Bertoglio 17 citations

Threatening events and stressful experiences can lead to maladaptive memories and related behaviors. Existing treatments often fail to address these issues linked to anxiety/stress-related disorders effectively. This review identifies dose ranges associated with specific actions across various psychedelics. We examined psilocybin/psilocin, lysergic acid diethylamide (LSD),...

The unpaved road of ayahuasca, a psychoactive brew, as a treatment for neuropathic pain: A review of mechanistic insights and clinical prospects

Brain Behavior and Immunity Integrative September 14, 2024 Bianca Castro Dos Santos, Ana Kéren Gomes Reis, Ricardo Aparecido Baptista Nucci et al. 1 citation

Neuropathic pain (NP), a debilitating and chronic condition often accompanied by comorbid depression, presents significant therapeutic challenges. While conventional pharmacological treatments, though valuable, usually fall short in addressing their multifaceted nature, the pursuit of innovative solutions has led to the exploration of ayahuasca , a psychedelic brew originating from Amazonian...

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

Cellular and Molecular Life Sciences September 10, 2024 Klemens Egger, Helena Aicher, Paul Cumming et al. 30 citations

The potent hallucinogen N,N-dimethyltryptamine (DMT) has garnered significant interest in recent years due to its profound effects on consciousness and its therapeutic psychopotential. DMT is an integral (but not exclusive) psychoactive alkaloid in the Amazonian plant-based brew ayahuasca, in which admixture of several β-carboline monoamine oxidase A (MAO-A) inhibitors potentiate the activity...

Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science.

Journal of Studies on Alcohol and Drugs September 1, 2024 Brian Rush, Olivia Marcus, Sara García et al. 12 citations

This article focuses on the outcomes at 1 year post-treatment of a naturalistic evaluation of services provided through the Takiwasi Centre, an accredited Peruvian therapeutic community offering an ayahuasca-assisted, integrative treatment program for addiction rehabilitation. Participants (n = 52) completed structured interviews and a battery of validated instruments. Outcome measures included...

DOI: 10.15288/jsad.23-00005 (opens in new tab) Full text (opens in new tab) Addiction-treatment Psychedelic-therapy Ayahuasca-healing Alternative-medicine +1

Purging to Cleanse: A Qualitative Study of Ayahuasca Healing at a Drug Treatment Center in Peru.

Journal of Studies on Alcohol and Drugs September 1, 2024 Svět Lustig Vijay, Magdalena Harris, Fabio Friso et al. 1 citation

Ayahuasca, an entheogen from the Amazon rainforest, has garnered growing interest for treating substance dependence. To date, there is little research concerning the act of ayahuasca-related purging (mainly vomiting), which is considered to be central to healing during ayahuasca rituals. This study explored practitioner perspectives on purging during ayahuasca rituals at the Takiwasi Center in...

DOI: 10.15288/jsad.22-00429 (opens in new tab) Full text (opens in new tab) Ayahuasca Traditional-medicine Psychedelic-therapy Indigenous-healing +1

Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.

Pharmacological Research September 1, 2024 Giorgia Caspani, Simon Ruffell, WaiFung Tsang et al. 13 citations

Psychedelics have emerged as promising therapeutics for several psychiatric disorders. Hypotheses around their mechanisms have revolved around their partial agonism at the serotonin 2 A receptor, leading to enhanced neuroplasticity and brain connectivity changes that underlie positive mindset shifts. However, these accounts fail to recognise that the gut microbiota, acting via the gut-brain...

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis

BMJ August 21, 2024 Trevor Thompson, Ping-Tao Tseng, Chih-Wei Hsu et al. 24 citations

Abstract Objective To evaluate the comparative effectiveness and acceptability of oral monotherapy using psychedelics and escitalopram in patients with depressive symptoms, considering the potential for overestimated effectiveness due to unsuccessful blinding. Design Systematic review and Bayesian network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials,...

Christ returns from the jungle: Ayahuasca religion as mystical healing

Journal of Psychedelic Studies August 16, 2024 Bonnie Glass‐coffin 1 citation

Christ Returns from the Jungle is an anthropological inquiry into the recent expansion from South America to Europe of the ayahuasca-based Santo Daime New Religious Movement (NRM).In it, the author addresses important research questions that could be used as a model for the study of all globalizing NRM's.These include the following: Who are the Europeans that choose to join this movement and...

Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services.

BMJ Case Reports August 14, 2024 Morven Rosemary Baker, Christopher Iain O'Shea 1 citation

Ayahuasca is a plant-based psychoactive decoction, traditionally used by indigenous Amazonian peoples, which commonly contains the hallucinogen N,N-dimethyltryptamine (DMT). There is now growing interest across the Western world in psychedelics including Ayahuasca.This case describes a previously well male with no risk factors for adverse psychiatric outcomes or forensic history. Following...

DOI: 10.1136/bcr-2024-260648 (opens in new tab) Full text (opens in new tab) Ayahuasca Drug-induced psychosis Psychedelic drugs Violent behavior +1

Galactic transmissions from tantra bros, pu$$y priestesses, red-pilled starseeds, and ayahuasca girls: Decoding the pedagogies of conspiritual life coaching

The Review of Education Pedagogy & Cultural Studies August 9, 2024 Sandro R. Barros, Jennifer A. Sandlin

The COVID-19 pandemic spurred the growth of online wellness influencers who promote products and treatments to address spiritual distress by incorporating conspiracy theories into their messaging. In this article we investigate the rise of the “conspiritual life coach,” a subset of wellness influencers that emerged during the pandemic. We analyze their pedagogical approaches, illustrating how...

Learning Animacy Through Embodying Others: Plant Diets in the Peruvian Amazon

University of Chicago August 1, 2024 Lorna Hadlock

A hallucinogenic brew called ayahuasca has increasingly played a role in drawing people from around the world to the Peruvian Amazon. They come seeking healing and spiritual encounters. As ayahuasca tourism has grown, it has exceeded its designation as mere tourism. Some of the foreigners (mostly Westerners) who come to the jungle for ayahuasca engage in long-term shamanic training with local...